SOTAC PHARMACEUTICALS
Back to Balance Sheet
|
SOTAC PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹58 Cr | ₹52 Cr | ₹44 Cr | ₹46 Cr | ₹28 Cr |
What is the latest Total Current Liabilities ratio of SOTAC PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹58 Cr |
| Mar2025 | ₹52 Cr |
| Mar2024 | ₹44 Cr |
| Mar2023 | ₹46 Cr |
| Mar2022 | ₹28 Cr |
How is Total Current Liabilities of SOTAC PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹58 Cr | 13.21 | |
| Mar2025 | ₹52 Cr | 17.88 | |
| Mar2024 | ₹44 Cr | -4.54 | |
| Mar2023 | ₹46 Cr | 65.96 | |
| Mar2022 | ₹28 Cr | - | |
Compare Total Current Liabilities of peers of SOTAC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOTAC PHARMACEUTICALS | ₹142.3 Cr | 5.3% | 23.2% | -27.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,291.0 Cr | -1.8% | 7.6% | 11.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹305,014.0 Cr | 3.7% | 27.2% | 71.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,333.0 Cr | -2.3% | 1.5% | 23.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,017.0 Cr | 0.6% | 13.4% | 15.7% | Stock Analytics | |
| CIPLA | ₹112,539.0 Cr | -1.3% | 6.1% | -6.9% | Stock Analytics | |
SOTAC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOTAC PHARMACEUTICALS | 5.3% |
23.2% |
-27.8% |
| SENSEX | 0.7% |
11.7% |
-2% |
You may also like the below Video Courses